Ronald M. van Dam, MD, PhD

Training

Medical School at Groningen University and Amsterdam Free University, The Netherlands.

Surgical training at Maastricht University Medical Center and Eindhoven Deaconess Hospital, The Netherlands

Fellow in Gastro-Intestinal- and Oncologic Surgery at Maastricht University Medical Center, The Netherlands.

Currently
Consultant surgeon in HPB surgical oncology at the European HPB Center Aachen Maastricht of Maastricht University Medical Center, The Netherlands. Clinical lead in Minimal Impact, Robotic and Personalized HPB Oncology.

Consultant surgeon in HPB surgical oncology at Universitäts Klinikum Aachen, Germany.

Executive clinical lead European Surgical Center Aachen Maastricht, Aachen Germany / Maastricht, The Netherlands

Principal investigator of the international multicenter randomized controlled ORANGE II Plus trial, DRAGON trials and BPrecise trials. Minimizing the impact of treatments by optimizing and personalizing care in liver and pancreas oncology, assessing the benefits of laparoscopic, interventional and guided systemic strategies.